Judit Sanchez Gil, Hirotaka Fudaba, Hiroaki Wakimoto. Chimeric oncolytic adenovirus to break away from neutralizing antibodies. Molecular therapy : the journal of the American Society of Gene Therapy. 2024. 32. 4. 875-877
Fumiyuki Yamasaki, Hirotaka Fudaba, Kenichiro Asano, Takashi Sasayama, Manabu Natsumeda, Taichi Shimabukuro, Kotaro Taguchi, Shinichiro Koizumi, Noriyuki Nakayama, Kentaro Fujii, et al. Multidrug chemotherapy, whole-brain radiation and cytarabine therapy for primary central nervous system lymphoma in elderly patients with dose modification based on geriatric assessment: study protocol for a phase II, multicentre, non-randomised study. BMJ open. 2023. 13. 4. e071350
Shinji Yamashita, Hideo Takeshima, Nobuhiro Hata, Hiroyuki Uchida, Naoki Shinojima, Kiyotaka Yokogami, Yoshiteru Nakano, Kiyohiko Sakata, Hirotaka Fudaba, Toshiyuki Enomoto, et al. Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group. Journal of neuro-oncology. 2023. 162. 2. 425-433
Hirotaka Fudaba, Hiroaki Wakimoto. Oncolytic virus therapy for malignant gliomas: entering the new era. Expert opinion on biological therapy. 2023. 23. 3. 269-282
